Left Atrial Strain for Predicting Atrial Fibrillation Onset in Hypertensive Patients.
Aged
Aged, 80 and over
Atrial Fibrillation
/ diagnosis
Atrial Function, Left
Biomechanical Phenomena
Echocardiography, Doppler, Pulsed
Electrocardiography, Ambulatory
Essential Hypertension
/ complications
Female
Heart Atria
/ diagnostic imaging
Humans
Male
Middle Aged
Predictive Value of Tests
Prognosis
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Atrial fibrillation
Hypertension
Speckle tracking
Journal
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
ISSN: 1179-1985
Titre abrégé: High Blood Press Cardiovasc Prev
Pays: New Zealand
ID NLM: 9421087
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
25
02
2019
accepted:
01
07
2019
pubmed:
17
7
2019
medline:
3
9
2019
entrez:
17
7
2019
Statut:
ppublish
Résumé
We aimed to find new predictive parameters for atrial fibrillation (AF) onset in hypertensive patients using two-dimensional (2D) conventional and speckle tracking echocardiography of the left atrium (LA). One hundred and eight patients with essential hypertension (HTN) were prospectively enrolled, from which 67 patients had no other important comorbidities (HTN group), while 41 patients had a recent AF episode, but were in sinus rhythm at the moment of enrollment (HTN and AF group). LA diameters and maximal volume, LV mass, LV ejection fraction and diastolic function were assessed through 2D conventional echocardiography. Moreover, peak longitudinal and contractile strain of LA walls (PALS and PACS, respectively) were analyzed by speckle tracking technique. Patients were followed up for 1 year and recurrent 24-h rhythm monitoring was done, in order to identify atrial fibrillation. Age and time from diagnosis of HTN were higher in HTN and AF group than in HTN group (68.02 ± 19 years versus 57.2 ± 1.52 years, p = 0.001 and 62.2 ± 9.2 months versus 40.4 ± 6.4 months, p = 0.04). All LA diameters and LA maximal volume were significantly larger in HTN and AF group (for LA antero-posterior diameter p = 0.02, for all the rest p < 0.0001). LV ejection fraction was preserved in both groups, being significantly lower in HTN and AF patients (58.44 ± 0.79 versus 60.75 ± 0.57, p = 0.02). LV mass was higher in HTN and AF group and these patients had also a more severe diastolic dysfunction, (E/A ratio 1.8 ± 0.51 versus 0.9 ± 0.02, p = 0.04) and lower septal and lateral A' velocities (p < 0.0001 and p = 0.002). The peak LA longitudinal and contractile strain values were also significantly lower in HTN and AF group versus HTN group (for all p < 0.0001). Among the echocardiographic parameters, we identified PALS and PACS as predictors for AF, with a good discriminating capacity (AUC = 0.88 for PALS and AUC = 0.86 for PACS). Compared to patients with isolated hypertension, patients with hypertension and AF display several echocardiographic differences. Among them, LA strain parameters could be useful predictors of AF occurrence in hypertensive patients.
Identifiants
pubmed: 31309456
doi: 10.1007/s40292-019-00326-4
pii: 10.1007/s40292-019-00326-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
331-337Subventions
Organisme : CREDO Project
ID : 49182
Références
J Am Coll Cardiol. 2008 Feb 26;51(8):802-9
pubmed: 18294563
Am J Cardiol. 2008 Jul 1;102(1):70-6
pubmed: 18572038
Cardiovasc Ultrasound. 2009 Feb 08;7:6
pubmed: 19200402
Circ Cardiovasc Imaging. 2010 May;3(3):231-9
pubmed: 20133512
J Am Soc Echocardiogr. 2011 Aug;24(8):898-908
pubmed: 21665431
JACC Cardiovasc Imaging. 2011 Jul;4(7):788-98
pubmed: 21757171
Cardiovasc Ultrasound. 2012 Dec 03;10:48
pubmed: 23199055
Int J Cardiol. 2013 Oct 3;168(3):1894-9
pubmed: 23333369
J Am Soc Hypertens. 2013 May-Jun;7(3):206-15
pubmed: 23538140
J Am Coll Cardiol. 2014 Feb 18;63(6):493-505
pubmed: 24291276
J Cardiovasc Med (Hagerstown). 2016 May;17(5):339-43
pubmed: 24838034
Am J Cardiol. 2014 Nov 1;114(9):1368-72
pubmed: 25245413
Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):1008-14
pubmed: 25750193
Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):235-250
pubmed: 28541499
Circ Cardiovasc Imaging. 2017 Oct;10(10):
pubmed: 29021263
Circ Res. 2018 Jan 19;122(2):352-368
pubmed: 29348255